Skip to content
value.today

Expanesthetics, Inc

PharmaceuticalsFounded 2012
Total raised
$7 M
4 rounds on record
Latest round
$1 M
Dec 2021
First round on record
Dec 2013
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Expanesthetics, Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2021$1 MNo. 4Under $2 million

Expanesthetics, Inc: Raise no. 4, Dec 2021

Investors in this round

33 investors had bought by the notice of Jan 7, 2022: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$14,858
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$745 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in California

People named in the notice

  • Brian Woodall · Executive Officer
  • Landon Ellis · Executive Officer
  • Mark Holman · Executive Officer, Director
  • Shane Austin · Executive Officer
  • Jenna Hansen · Director
  • Lon Hatamiya · Director
  • Richard Fowler · Director
  • Robert Erwin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Holman, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 7, 2022. Read the notice at the SEC.

equity, optionsSEC
Jul 2018$1 MNo. 3Under $2 million

Expanesthetics, Inc: Raise no. 3, Jul 2018

Investors in this round

57 investors had bought by the notice of Mar 5, 2019: 57 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$445,718 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in California

People named in the notice

  • Christopher Stone · Executive Officer
  • Landon Ellis · Executive Officer
  • Mark Holman · Executive Officer, Director
  • Shane Austin · Executive Officer
  • Jenna Hansen · Director
  • Lon Hatamiya · Director
  • Richard Fowler · Director
  • Robert Erwin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Holman, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Mar 5, 2019. Read the notice at the SEC.

optionsSEC
Sep 2017$1 MNo. 2Under $2 million

Expanesthetics, Inc: Raise no. 2, Sep 2017

Investors in this round

48 investors had bought by the notice of Mar 5, 2019: 48 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$10,080
What was sold
equity
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
more than a year
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$533,882 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in California

People named in the notice

  • Mark Holman · Executive Officer, Director
  • Shane Austin · Executive Officer
  • Jenna Hansen · Director
  • Lon Hatamiya · Director
  • Richard Fowler · Director
  • Robert Erwin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Holman, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 5, 2019. Read the notice at the SEC.

equitySEC
Dec 2013$3 MNo. 1$2 to $10 million

Expanesthetics, Inc: Raise no. 1, Dec 2013

Investors in this round

70 investors had bought by the notice of Sep 11, 2017: 70 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M (amount offered: indefinite)
Smallest investment taken
$2,500
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$720,467 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Mark Holman · Executive Officer, Director
  • Shane Austin · Executive Officer
  • Claire Pomeroy · Director
  • Lon Hatamiya · Director
  • Richard Fowler · Director
  • Robert Erwin · Director
  • Todd Strumwasser · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The above amounts were payments for executive officers and director compensation.”

Signed by Mark Holman, Ceo. Source: SEC Form D, newest notice filed Sep 11, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Expanesthetics, Inc had no revenue when it filed its newest notice of a funding round (Jan 2022).

    SEC Form D (revenue range) · Jan 2022

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jan 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Expanesthetics, Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 70 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Expanesthetics, Inc
NameRoleNamed in
Brian WoodallExecutive officerJan 2022
Landon EllisExecutive officerJan 2022
Mark HolmanExecutive officerJan 2022
Shane AustinExecutive officerJan 2022
Christopher StoneExecutive officerMar 2019
Jenna HansenDirectorJan 2022
Lon HatamiyaDirectorJan 2022
Mark HolmanDirectorJan 2022
Richard FowlerDirectorJan 2022
Robert ErwinDirectorJan 2022
Claire PomeroyDirectorSep 2017
Todd StrumwasserDirectorSep 2017